Accumulated Other Comprehensive Income (Loss)

12 Months Ended

Dec. 31, 2022

Equity [Abstract]

Accumulated Other Comprehensive Income (Loss)

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

Changes in our AOCI balances, net of tax, were as follows (in millions):

	Fair Value of Derivative Financial Instruments, net of tax		Foreign Currency Translation Adjustments (1)		Post-Employment Plan Adjustments, net of tax(1)		Total AOCI
Balance at December 31, 2020	$	(0.7)	$	407.3	$	(11.6)	$	395.0
OCI before reclassifications	(24.9)		(339.9)		7.4		(357.4)
Amounts reclassified from AOCI	3.6		—		(5.7)		(2.1)
Other comprehensive income (loss)	(21.3)		(339.9)		1.7		(359.5)
Balance at December 31, 2021	(22.0)		67.4		(9.9)		35.5
OCI before reclassifications	47.8		(82.4)		22.3		(12.3)
Amounts reclassified from AOCI	(1.3)		(43.6)		(5.3)		(50.2)
Other comprehensive income (loss)	46.5		(126.0)		17.0		(62.5)
Balance at December 31, 2022	$	24.5	$	(58.6)	$	7.1	$	(27.0)

(1) Amounts reclassified from AOCI relate to the divestiture of the Latin American businesses and Rosemont Pharmaceuticals. Refer to Note 3 for more information.